Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2004 1
2006 4
2007 2
2008 1
2009 2
2010 1
2011 5
2012 3
2013 3
2014 6
2015 7
2016 4
2017 11
2018 10
2019 4
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Results by year
Filters applied: . Clear all
Page 1
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N; WHO Pathogens Priority List Working Group. Tacconelli E, et al. Among authors: theuretzbacher u. Lancet Infect Dis. 2018 Mar;18(3):318-327. doi: 10.1016/S1473-3099(17)30753-3. Epub 2017 Dec 21. Lancet Infect Dis. 2018. PMID: 29276051
The global preclinical antibacterial pipeline.
Theuretzbacher U, Outterson K, Engel A, Karlén A. Theuretzbacher U, et al. Nat Rev Microbiol. 2020 May;18(5):275-285. doi: 10.1038/s41579-019-0288-0. Epub 2019 Nov 19. Nat Rev Microbiol. 2020. PMID: 31745331 Free PMC article. Review.
Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial.
Huttner A, Kowalczyk A, Turjeman A, Babich T, Brossier C, Eliakim-Raz N, Kosiek K, Martinez de Tejada B, Roux X, Shiber S, Theuretzbacher U, von Dach E, Yahav D, Leibovici L, Godycki-Cwirko M, Mouton JW, Harbarth S. Huttner A, et al. Among authors: theuretzbacher u. JAMA. 2018 May 1;319(17):1781-1789. doi: 10.1001/jama.2018.3627. JAMA. 2018. PMID: 29710295 Free PMC article. Clinical Trial.
Non-traditional Antibacterial Therapeutic Options and Challenges.
Theuretzbacher U, Piddock LJV. Theuretzbacher U, et al. Cell Host Microbe. 2019 Jul 10;26(1):61-72. doi: 10.1016/j.chom.2019.06.004. Cell Host Microbe. 2019. PMID: 31295426 Free article. Review.
Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials.
Huttner A, Verhaegh EM, Harbarth S, Muller AE, Theuretzbacher U, Mouton JW. Huttner A, et al. Among authors: theuretzbacher u. J Antimicrob Chemother. 2015 Sep;70(9):2456-64. doi: 10.1093/jac/dkv147. Epub 2015 Jun 11. J Antimicrob Chemother. 2015. PMID: 26066581 Review.
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.
Paul M, Daikos GL, Durante-Mangoni E, Yahav D, Carmeli Y, Benattar YD, Skiada A, Andini R, Eliakim-Raz N, Nutman A, Zusman O, Antoniadou A, Pafundi PC, Adler A, Dickstein Y, Pavleas I, Zampino R, Daitch V, Bitterman R, Zayyad H, Koppel F, Levi I, Babich T, Friberg LE, Mouton JW, Theuretzbacher U, Leibovici L. Paul M, et al. Among authors: theuretzbacher u. Lancet Infect Dis. 2018 Apr;18(4):391-400. doi: 10.1016/S1473-3099(18)30099-9. Epub 2018 Feb 16. Lancet Infect Dis. 2018. PMID: 29456043 Clinical Trial.
Pharmacokinetic/pharmacodynamic profile of voriconazole.
Theuretzbacher U, Ihle F, Derendorf H. Theuretzbacher U, et al. Clin Pharmacokinet. 2006;45(7):649-63. doi: 10.2165/00003088-200645070-00002. Clin Pharmacokinet. 2006. PMID: 16802848 Review.
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.
Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, Hope WW, Farkas A, Neely MN, Schentag JJ, Drusano G, Frey OR, Theuretzbacher U, Kuti JL; International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious Diseases. Roberts JA, et al. Among authors: theuretzbacher u. Lancet Infect Dis. 2014 Jun;14(6):498-509. doi: 10.1016/S1473-3099(14)70036-2. Epub 2014 Apr 24. Lancet Infect Dis. 2014. PMID: 24768475 Free PMC article. Review.
Analysis of the clinical antibacterial and antituberculosis pipeline.
Theuretzbacher U, Gottwalt S, Beyer P, Butler M, Czaplewski L, Lienhardt C, Moja L, Paul M, Paulin S, Rex JH, Silver LL, Spigelman M, Thwaites GE, Paccaud JP, Harbarth S. Theuretzbacher U, et al. Lancet Infect Dis. 2019 Feb;19(2):e40-e50. doi: 10.1016/S1473-3099(18)30513-9. Epub 2018 Oct 15. Lancet Infect Dis. 2019. PMID: 30337260
Critical analysis of antibacterial agents in clinical development.
Theuretzbacher U, Bush K, Harbarth S, Paul M, Rex JH, Tacconelli E, Thwaites GE. Theuretzbacher U, et al. Nat Rev Microbiol. 2020 May;18(5):286-298. doi: 10.1038/s41579-020-0340-0. Epub 2020 Mar 9. Nat Rev Microbiol. 2020. PMID: 32152509 Review.
64 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page